NEWSMAKING INNOVATION ACCESSIBLE: Breakthrough Published in Biomaterials

4 Sep 2025

๐Ÿš€ MAKING INNOVATION ACCESSIBLE: Breakthrough Published in Biomaterials!

SHIFTBIO proudly announces groundbreaking research published in Biomaterials (IF 14.0+) - solving one of medicine's greatest challenges: turning unstable therapeutics into powerful, targeted treatments.

๐ŸŽฏ The Challenge We Solved: Apelin peptides showed promise for Pulmonary Arterial Hypertension (PAH) but vanished within hours in the bloodstream - until now.

โšก Our Innovation: โœ… IFITM3-based EV platform - engineered for optimal C-terminal cargo display โœ… 24-hour plasma stability vs. <1 hour for free peptides โœ… Targeted PAH delivery using our novel CARSKNKDC peptide โœ… Foundation for NSM 2.0 - next-generation scaffold technology

๐Ÿ’ฅ Real Impact: Reversed vascular remodeling and restored cardiac function in preclinical PAH models - addressing a critical unmet medical need affecting millions worldwide.

This is how we turn the impossible into possible.
Ready to see what's next? ๐Ÿ‘€ 

https://www.sciencedirect.com/science/article/pii/S0142961225003576